Hematological, Biochemical and Renal Changes in Patients of Multiple Myeloma Treated with Bortezomib Based Triple Drug Chemotherapy.
The Journal of the Association of Physicians of India（2019）
摘要
BTD is safe, effective in reversing renal impairment and improves survival in newly diagnosed cases of MM with renal impairment.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要